🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.20.10033 Boehringer Ingelheim Investigational Site
Start Date
2008-02
Trial ID
NCT00622284
The primary objective is to demonstrate, after 52 weeks of treatment, the n...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2007-03
Trial ID
NCT00449605
Treatments Being Tested
The purpose of this study is to determine if albiglutide is safe and effect...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00838903
This study will evaluate the efficacy and tolerability of saxagliptin compa...
Status
Completed
Location
Research Site
Start Date
2009-10
Trial ID
NCT01006603
Treatments Being Tested
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
The purpose of this study is to demonstrate that the rosiglitazone/glimepir...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-04
Trial ID
NCT01453049
Treatments Being Tested
Primary objective of this study is to confirm the efficacy of HOE490 O (gli...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-05
Trial ID
NCT00924573
Treatments Being Tested
This two-phase study was to examine if 16 weeks of treatment with sitaglipt...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10-24
Trial ID
NCT01477853
Phase 3 study to examine treatment with ITCA 650 compared to glimepiride wh...
Status
Withdrawn
Location
Intarcia Therapeutics, Inc
Start Date
2013-02
Trial ID
NCT01455922
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01357252
Treatments Being Tested